Project Grant HT94252410626
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$673K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Binghamton, NY 13902, USA
Similar Awards
This federal Project Grant award of $1,021,409.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Illinois to investigate the underlying neurobiology of non-motor symptoms in Parkinson's disease. The research aims to elucidate the role of serotonin system plasticity in the development of these disabling non-motor complications, which can include cognitive, psychiatric, and...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,493,233 to The Trustees of Columbia University in the City of New York to fund research on gene therapy in a nonhuman primate model of cognitive defects in Parkinson's disease. The award commenced on November 15, 2024 and is set to be completed by November 14, 2027. The university's Health Sciences Division will leverage its...
This $2,000,000 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research on the interrelationship between the PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson's disease. The award, with a performance period from June 1, 2025 to May 31, 2028, was granted to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical...
The federal Project Grant award of $200,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research conducted by Northwestern University to elucidate the neural basis of hallucinations in Parkinson's disease. The award, effective July 1, 2025 through June 30, 2027, will enable Northwestern University's researchers to investigate this critical medical challenge and develop innovative solutions to transform healthcare for military...
This federal Project Grant award in the amount of $811,942 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the J. David Gladstone Institutes, a non-profit biomedical research organization, to investigate genetic factors conferring susceptibility to toxicant-induced Parkinson's disease. The research involves a sub-award to the Northern California Institute For Research And...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
The Department of the Army Medical Command awarded a $1,463,982 Project Grant to The Research Foundation for the State University of New York (RF SUNY) under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project titled "Defining the ABI1-Mediated Resistance to Enzalutamide" to investigate new treatments for military health priorities. The Research Foundation for the State University of New York, which serves as the fiscal...
The Pennsylvania State University College of Medicine received a $1.29 million project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The four-year award will fund research into maladaptive nigrovagal pathophysiology in parkinsonism. Through September 2025, the university will investigate medical solutions for neurological conditions affecting service members and veterans, with the goal of transforming...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,938,711 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) on April 1, 2024. The grant will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder that causes progressive muscle weakness and wasting. The project aims to transform health care for service members and the public by conducting...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....